BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35617689)

  • 21. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.
    Oki Y; Chuang H; Chasen B; Jessop A; Pan T; Fanale M; Dabaja B; Fowler N; Romaguera J; Fayad L; Hagemeister F; Rodriguez MA; Neelapu S; Samaniego F; Kwak L; Younes A
    Br J Haematol; 2014 Apr; 165(1):112-6. PubMed ID: 24386943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten-year survival outcomes for patients with early stage classical Hodgkin lymphoma: An analysis from Kentucky Cancer Registry.
    Myint ZW; Shrestha R; Siddiqui S; Slone S; Huang B; Ramlal R; Monohan GP; Hildebrandt GC; Saeed H
    Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):17-22. PubMed ID: 31629724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma.
    Herbst C; Rehan FA; Skoetz N; Bohlius J; Brillant C; Schulz H; Monsef I; Specht L; Engert A
    Cochrane Database Syst Rev; 2011 Feb; (2):CD007110. PubMed ID: 21328291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.
    King MT; Donaldson SS; Link MP; Natkunam Y; Advani RH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):67-75. PubMed ID: 25863755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies).
    Mou E; Advani RH; von Eyben R; Rosenberg SA; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):444-451. PubMed ID: 33385495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
    Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
    J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of favorable early-stage hodgkin's lymphoma treatments: a single-institution review.
    Samant R; Alomary I; Alsaeed E; Al-Jasir B; Bence-Bruckler I; Cross P; Genest P; Huebsch L
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1166-70. PubMed ID: 19695788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma.
    Song MK; Chung JS; Lee JJ; Jeong SY; Lee SM; Hong JS; Chong A; Moon JH; Kim JH; Lee SM; Kim SJ; Shin HJ
    Cancer Sci; 2013 Dec; 104(12):1656-61. PubMed ID: 24033666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decisional early interim (18)F-fluoro-2-deoxy-D-glucose positron emission tomography after two cycles of chemotherapy in de novo Hodgkin lymphoma.
    Iltis A; Eder V; Blasco H; Colombat P; Sénécal D
    Acta Haematol; 2015; 133(2):172-8. PubMed ID: 25301496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical profile and outcome of classical Hodgkin lymphoma treated with a risk-adapted approach in a tertiary cancer center in India.
    Parambil BC; Narula G; Prasad M; Shah S; Shet T; Shridhar E; Khanna N; Laskar S; Gujral S; Sankaran H; Banavali S
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28058. PubMed ID: 31724304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy or Combined Modality Therapy for Early-stage Hodgkin Lymphoma.
    Torok JA; Wu Y; Chino J; Prosnitz LR; Beaven AW; Kim GJ; Kelsey CR
    Anticancer Res; 2018 May; 38(5):2875-2881. PubMed ID: 29715111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy.
    Bartlett NL
    Am Soc Clin Oncol Educ Book; 2013; ():374-80. PubMed ID: 23714551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles.
    Długosz-Danecka M; Szmit S; Kocurek A; Koźlik P; Giza A; Zimowska-Curyło D; Małkowski B; Sowa-Staszczak A; Kużdżał J; Jurczak W
    Pol Arch Intern Med; 2019 Apr; 129(4):259-266. PubMed ID: 30945698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes.
    Kumar A; Burger IA; Zhang Z; Drill EN; Migliacci JC; Ng A; LaCasce A; Wall D; Witzig TE; Ristow K; Yahalom J; Moskowitz CH; Zelenetz AD
    Haematologica; 2016 Oct; 101(10):1237-1243. PubMed ID: 27390360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy alone or combined chemotherapy and involved field radiotherapy in favorable risk early-stage classical Hodgkin lymphoma-a 10 years experience.
    Ali S; Basit A; Kazmi AS; Sidhu A; Badar F; Hameed A
    Pak J Med Sci; 2016; 32(6):1408-1413. PubMed ID: 28083035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.
    Gandikota N; Hartridge-Lambert S; Migliacci JC; Yahalom J; Portlock CS; Schöder H
    Cancer; 2015 Jun; 121(12):1985-92. PubMed ID: 25739719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
    J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is combined modality therapy necessary for advanced Hodgkin's disease?
    Mendenhall NP; Bennett CJ; Lynch JW
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):583-92. PubMed ID: 9231683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consolidation Radiation Therapy for Patients With Advanced Hodgkin Lymphoma in Complete Metabolic Response According to PET-CT or Gallium Imaging.
    Song EJ; Torok J; Wu Y; Chino J; Prosnitz LR; Beaven AW; Kelsey CR
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):145-151. PubMed ID: 29358045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.